WD Rutherford’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,714
Closed -$338K 73
2024
Q3
$338K Sell
1,714
-11,914
-87% -$2.48M 0.16% 68
2024
Q2
$2.82M Sell
13,628
-936
-6% -$212K 1.41% 31
2024
Q1
$3.95M Sell
14,564
-155
-1% -$37K 2.04% 17
2023
Q4
$3.18M Sell
14,719
-680
-4% -$134K 1.85% 24
2023
Q3
$3.02M Buy
15,399
+9,361
+155% +$1.92M 2.07% 19
2023
Q2
$1.27M Buy
6,038
+40
+0.7% +$7.96K 0.81% 38
2023
Q1
$1.21M Sell
5,998
-5
-0.1% -$1.13K 0.85% 38
2022
Q4
$1.31M Sell
6,003
-75
-1% -$16.4K 1.03% 35
2022
Q3
$1.2M Sell
6,078
-140
-2% -$30.2K 0.96% 39
2022
Q2
$1.33M Buy
6,218
+125
+2% +$30.5K 1.03% 37
2022
Q1
$1.73M Buy
6,093
+115
+2% +$35.5K 0.99% 39
2021
Q4
$2.25M Sell
5,978
-72
-1% -$28K 1.14% 35
2021
Q3
$2.5M Buy
6,050
+45
+0.7% +$18.7K 1.36% 32
2021
Q2
$2.22M Buy
6,005
+145
+2% +$48.4K 1.24% 35
2021
Q1
$1.7M Buy
5,860
+1,420
+32% +$395K 1.06% 38
2020
Q4
$1.11M Buy
+4,440
New +$1.06M 0.7% 43

Other funds holding CRL

WD Rutherford's CRL Position: Q4 2024 in Review

WD Rutherford sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 1,714 shares — an estimated $338K sold.

WD Rutherford first reported a position in CRL in Q4 2020 and held it in 16 quarters. The position peaked at $3.95M in Q1 2024. 636 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • WD Rutherford reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • WD Rutherford sold 1,714 Charles River Laboratories shares in Q4 2024, an estimated $338K.
  • WD Rutherford first reported a position in Charles River Laboratories in Q4 2020 and held it in 16 quarters.
  • WD Rutherford's Charles River Laboratories position peaked at $3.95M in Q1 2024.
  • 636 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on WD Rutherford's 13F filing for Q4 2024, filed 30 Jan 2025.